Home › APNewsBreak: NY bid to halt Alzheimer's drug swap
 

Keywords :   


APNewsBreak: NY bid to halt Alzheimer's drug swap

2014-09-16 02:32:12| Biotech - Topix.net

New York's attorney general filed a federal lawsuit Monday seeking to stop a manufacturer from discontinuing its drug widely used to treat Alzheimer's patients, arguing the company is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year. Attorney General Eric Schneiderman alleges anti-trust and state law violations by Dublin-based Actavis PLC and New York subsidiary Forest Laboratories, which Actavis recently acquired for $28 billion.

Tags: drug bid halt swap

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.06Eastern North Pacific Tropical Weather Outlook
17.06Atlantic Tropical Weather Outlook
17.06Labour accuses Tories of planning unfunded tax cuts
17.06Petrol prices far higher than they should be, says RAC
17.06Wrap sold in WH Smith recalled over E. coli fears
17.06Atlantic Tropical Weather Outlook
17.06Eastern North Pacific Tropical Weather Outlook
17.06Pixar's Inside Out 2 sees record opening weekend
More »